Literature DB >> 21902598

Cognitive function in prepubertal children with obstructive sleep apnea: a modifying role for NADPH oxidase p22 subunit gene polymorphisms?

David Gozal1, Abdelnaby Khalyfa, Oscar Sans Capdevila, Leila Kheirandish-Gozal, Ahamed A Khalyfa, Jinkwan Kim.   

Abstract

Pediatric obstructive sleep apnea (OSA) may lead to neurocognitive dysfunction, but not in everyone affected. The frequencies of NADPH oxidase (NOX) polymorphisms in the p22phox subunit were similar between children with OSA and controls, except for rs6520785 and rs4673, the latter being significantly more frequent among the OSA children without deficits than with deficits (p<0.02). Similarly, 8-hydroxydeoxyguanine urine levels and NOX activity were lower among children without cognitive deficits and particularly among those with the rs4673 polymorphism. Thus, polymorphisms within the NOX gene or its functional subunits may account for important components of the variance in cognitive function deficits associated with OSA in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21902598      PMCID: PMC3250922          DOI: 10.1089/ars.2011.4189

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  The C242T CYBA polymorphism as a major determinant of NADPH oxidase activity in patients with cardiovascular disease.

Authors:  P Mehranpour; S S Wang; R R Blanco; W Li; Q Song; B Lassègue; S I Dikalov; H Austin; A M Zafari
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

2.  NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea.

Authors:  Guanxia Zhan; Faridis Serrano; Polina Fenik; Ray Hsu; Linghao Kong; Domenico Pratico; Eric Klann; Sigrid C Veasey
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

Review 3.  NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair.

Authors:  Fan Jiang; Yun Zhang; Gregory J Dusting
Journal:  Pharmacol Rev       Date:  2011-01-12       Impact factor: 25.468

4.  C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children.

Authors:  David Gozal; Valerie McLaughlin Crabtree; Oscar Sans Capdevila; Lisa A Witcher; Leila Kheirandish-Gozal
Journal:  Am J Respir Crit Care Med       Date:  2007-03-30       Impact factor: 21.405

Review 5.  Neurobehavioral morbidity associated with disordered breathing during sleep in children: a comprehensive review.

Authors:  Dean W Beebe
Journal:  Sleep       Date:  2006-09       Impact factor: 5.849

6.  Physical activity attenuates intermittent hypoxia-induced spatial learning deficits and oxidative stress.

Authors:  David Gozal; Deepti Nair; Aviv D Goldbart
Journal:  Am J Respir Crit Care Med       Date:  2010-03-11       Impact factor: 21.405

Review 7.  Neurocognitive dysfunction in children with sleep disorders.

Authors:  Leila Kheirandish; David Gozal
Journal:  Dev Sci       Date:  2006-07

Review 8.  NOX enzymes in the central nervous system: from signaling to disease.

Authors:  Silvia Sorce; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

9.  Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea.

Authors:  Deepti Nair; Ehab A Dayyat; Shelley X Zhang; Yang Wang; David Gozal
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

  9 in total
  20 in total

Review 1.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

Review 2.  The role inflammatory response genes in obstructive sleep apnea syndrome: a review.

Authors:  Francisco Fábio Ferreira de Lima; Diego R Mazzotti; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-07-23       Impact factor: 2.816

3.  CrossTalk proposal: the intermittent hypoxia attending severe obstructive sleep apnoea does lead to alterations in brain structure and function.

Authors:  David Gozal
Journal:  J Physiol       Date:  2013-01-15       Impact factor: 5.182

4.  Factors associated with excessive daytime sleepiness in patients with severe obstructive sleep apnea.

Authors:  John H Jacobsen; Lei Shi; Babak Mokhlesi
Journal:  Sleep Breath       Date:  2012-06-24       Impact factor: 2.816

5.  Obstructive sleep apnea in obese community-dwelling children: the NANOS study.

Authors:  María Luz Alonso-Álvarez; José Aurelio Cordero-Guevara; Joaquin Terán-Santos; Mónica Gonzalez-Martinez; María José Jurado-Luque; Jaime Corral-Peñafiel; Joaquin Duran-Cantolla; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

6.  Preliminary functional MRI neural correlates of executive functioning and empathy in children with obstructive sleep apnea.

Authors:  Leila Kheirandish-Gozal; Keith Yoder; Richa Kulkarni; David Gozal; Jean Decety
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

7.  Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity.

Authors:  D Nair; V Ramesh; D Gozal
Journal:  Neuroscience       Date:  2012-10-11       Impact factor: 3.590

Review 8.  Central and peripheral factors contributing to obstructive sleep apneas.

Authors:  Jan-Marino Ramirez; Alfredo J Garcia; Tatiana M Anderson; Jenna E Koschnitzky; Ying-Jie Peng; Ganesh K Kumar; Nanduri R Prabhakar
Journal:  Respir Physiol Neurobiol       Date:  2013-06-11       Impact factor: 1.931

Review 9.  Genotype-phenotype interactions in pediatric obstructive sleep apnea.

Authors:  Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2013-04-03       Impact factor: 1.931

Review 10.  Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs.

Authors:  David Gozal; Ramon Farré; F Javier Nieto
Journal:  Sleep Med Rev       Date:  2015-06-03       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.